AusPAR: Eluxadoline

Australian Public Assessment Report

AusPAR

AusPAR: Eluxadoline [Viberzi] [PDF, 961.18 KB]

AusPAR: Eluxadoline [Viberzi] [Word, 1.65 MB]

Attachment: Extract from Clinical Evaluation Report: Eluxadoline [Viberzi] [PDF, 1.76 MB]

Attachment: Extract from Clinical Evaluation Report: Eluxadoline [Viberzi] [Word, 4.28 MB]

Device/Product Name

Viberzi

Active ingredients

Eluxadoline

AusPAR Date

16 May 2018

Published

25 June 2018

Submission Number

PM-2016-02313-1-1

Submission Type

New chemical entity

Decision

Withdrawn